Drug consumption and air pollution: An overview

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 12, 2010, Pages 1300-1315

  Menichini, Federica ^a   Mudu, Pierpaolo ^b  

^a UNIVERSITY OF CALABRIA   (Italy)

^b WHO European Centre for Environment and Health   (Italy)

Author keywords

Air pollution; Asthma; Bronchodilators; Drug consumption; Respiratory disease

Indexed keywords

ACETYLCYSTEINE; ANTIHISTAMINIC AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHROMONE DERIVATIVE; CORTICOSTEROID; FENOTEROL; FLUTICASONE PROPIONATE; METHACHOLINE; METHYLXANTHINE; NITROGEN DIOXIDE; OZONE; SALBUTAMOL; SULFUR DIOXIDE; TERBUTALINE; THEOPHYLLINE;

ACUTE RESPIRATORY TRACT DISEASE; AIR POLLUTANT; AIR POLLUTION; ASTHMA; CAR; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; DIESEL ENGINE; DRUG USE; ELECTRIC POWER PLANT; ENVIRONMENTAL EXPOSURE; HUMAN; LOGISTIC REGRESSION ANALYSIS; PHYSICAL DISEASE BY BODY FUNCTION; POLLUTION MONITORING; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKE;

AIR POLLUTANTS; AIR POLLUTION; ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS; RESPIRATORY SYSTEM AGENTS; RESPIRATORY TRACT DISEASES; TIME FACTORS;

EID: 78649516886     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2033     Document Type: Review

References (49)

1. American Thoracic Society. What constitutes and adverse health effect of air pollution? Am J Respir Crit Care Med 2000; 161: 665-673.
2. WHO. Air quality guidelines global update, 2005; Copenhagen, World Health Organization: 2006.
3. Katsouyanni K, Touloumi G, Spix C, et al. Short-term effects of ambient sulphur dioxide and particulate matter on mortality in 12 European cities: results from time series data from the APHEA project. Air Pollution and Health: a European Approach. Br Med J 1997; 314(7095): 1658-1663.
4. Burnett RT, Stieb D, Brook JR, et al. Associations between short-term changes in nitrogen dioxide and mortality in Canadian cities. Arch Environ Health 2004; 59(5): 228-236.
5. Samet JM, et al. The National Morbidity, Mortality, and Air Pollution Study (NMMAPS). Part 2. Morbidity and Mortality from Air Pollution in the United States. Boston, MA, Health Effects Institute: 2000.
6. Krzyzanowski M, Kuna-Dibbert B, Schneider J (eds). Health effects of transport-related air pollution. Copenhagen, WHO Regional Office for Europe: 2005.
7. WHO. Health Aspects of Air Pollution. Copenhagen, WHO Regional Office for Europe: 2004.
8. Moolgavkar SH, Luebeck EG, Anderson EL. Air pollution and hospital admissions for respiratory causes in Minneapolis-St. Paul and Birmingham. Epidemiology 1997; 8(4): 364-370.
9. Fusco D, Forastiere F, Michelozzi P, et al. Air pollution and hospital admissions for respiratory conditions in Rome, Italy. Eur Respir J 2001; 17: 1143-1150.
10. Slaughter JC, Lumley T, Sheppard L, Koenig JQ, Shapiro GG. Effects of ambient air pollution on symptom severity and medication use in children with asthma. Ann Allergy Asthma Immunol 2003; 91(4): 346-353.
11. Dockery DW, Pope CA III. Acute respiratory effects of particulate air pollution. Annu Rev Public Health 1994; 15: 107-132.
12. Albert RK, Spiro SG, Jett JR. Clinical Respiratory Medicine 3rd edition. In Airway Diseases. β2-Agonists, Anticholinergics, and Other Nonsteroid Drugs, Chapter 36, Section IX. Barnes PJ (ed). Mosby: London, 2008; 471-478.
13. Laurent O, Pedrono G, Filleul L, et al. Influence of socioeconomic deprivation on the relation between air pollution and β-agonists sales for asthma. Chest 2009; 135(3): 717-723.
14. National Asthma Education and Prevention Program. Expert Panel Report III: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD, National Heart, Lung, and Blood Institute: 2007.
15. MacNee W. Acute exacerbations of COPD. Swiss Med Wkly 2003; 133(17-18): 247-257.
16. Pauwels R, O'Byrne PM, Lenfant C (eds.) Lung Biology in Health and Disease. In Beta2-Agonists in Asthma Treatment, Vol. 106, Dekker, New York (USA), 1997.
17. Yawn BP. Differential assessment and management of asthma vs chronic obstructive pulmonary disease. Medscape J Med 2009; 11(1): 20.
18. von Klot S, Wölke G, Tuch T, et al. Increased asthma medication use in association with ambient fine and ultrafine particles. Eur Respir J 2002; 20(3): 691-702.
19. Chimonas MA, Gessner BD. Airborne particulate matter from primarily geologic, non-industrial sources at levels below National Ambient Air Quality Standards is associated with outpatient visits for asthma and quick-relief medication prescriptions among children less than 20 years old enrolled in Medicaid in Anchorage, Alaska. Environ Res 2007; 103(3): 397-404.
20. van der Zee S, Hoek G, Boezen HM, Schouten JP, van Wijnen JH, Brunekreef B. Acute effects of urban air pollution on respiratory health of children with and without chronic respiratory symptoms. Occup Environ Med 1999; 56(12): 802-812.
21. Hurley F, et al. Service contract for carrying out cost-benefit analysis of air quality related issues, in particular in the Clean Air for Europe (CAFE) programme. Methodol Paper 2005; 2: 1-53.
22. Just J, Segala C, Sahraoui F, Priol G, Grimfeld A, Neukirch F. Short-term health effects of particulate and photochemical air pollution in asthmatic children. Eur Respir J 2002; 20: 899-906.
23. Vegni FE, Castelli B, Auxilia F, Wilkinson P. Air pollution and respiratory drug use in the city of Como, Italy. Eur J Epidemiol 2005; 20(4): 351-358.
24. Anderson HR. Atkinson RW, Peacock JL, Marston L, Konstantinou K. Meta-analysis of time-series studies and panel studies of particulate matter (PM) and ozone (O3): report of a WHO task group. Geneva, World Health Organization: 2004.
25. Roemer W, Hoek G, Brunekreef B. Pollution effects on asthmatic children in Europe, the PEACE study. Clin Exp Allergy 2000; 30: 1067-1075.
26. Pitard A, Zeghnoun A, Courseaux A, et al. Short-term associations between air pollution and respiratory drug sales. Environ Res 2004; 95(1): 43-52.
27. Zeghnoun A, Beaudeau P, Carrat F, et al. Air pollution and respiratory drug sales in the City of Le Havre, France, 1993-1996. Environ Res 1999; 81(3): 224-230.
28. Lipsey MW, Wilson DB. Practical Meta-analysis. Thousand Oaks, CA, Sage: 2001.
29. Escamilla-Nuñez M, Barraza-Villarreal A, Hernandez-Cadena L, et al. Traffic-related air pollution and respiratory symptoms among asthmatic children, resident in Mexico City: the EVA cohort study. Respir Res 2008; 9: 74.
30. Segala C, Fauroux B, Just J, Pascual L, Grimfeld A, Neukirch F. Short-term effect of winter air pollution on respiratory health of asthmatic children in Paris. Eur Respir J 1998; 11(3): 677-685.
31. Hiltermann TJN, Stolk J, van der Zee SC, et al. Asthma severity and susceptibility to air pollution. Eur Respir J 1998; 11(3): 686-693.
32. Pope CA, Dockery DW, Spengler JD, Raizenne ME. .Respiratory health and PM10 pollution. A daily time series analysis. Am Rev Respir Dis 1991; 144(3 Pt 1): 668-674.
33. Roemer W, Hoek G, Brunekreef B, Haluszka J, Kalandidi A, Pekkanen J. Daily variations in air pollution and respiratory health in a multicentre study: the PEACE project. Eur Respir J 1998; 12(6): 1354-1361.
34. Gent JF, Koutrakis P, Belanger K, et al. Symptoms and medication use in children with asthma and traffic-related sources of fine particle pollution. Environ Health Perspect 2009; 117(7): 1168-1174.
35. Higgins BG, Francis HC, Yates CJ, et al. Effects of air pollution on symptoms and peak expiratory flow measurements in subjects with obstructive airways disease. Thorax 1995; 50: 149-155.
36. Sánchez J, Romieu I, Ruiz S, Pino P, Gutiérrez M. Acute effects of the breathing of industrial waste and of sulfur dioxide on the respiratory health of children living in the industrial area of Puchuncaví, Chile. Rev Panam Salud Publica 1999; 6(6): 384-391.
37. Zmirou D, Parent B, Potelon JL. Epidemiologic study of the health effects of atmospheric waste from an industrial and household refuse incineration plant. Rev Epidemiol Sante Publique 1984; 32(6): 391-397.
38. Beaudeau P, Bonmati C, Boudhabhay O, et al. The use of drug consumption to monitor the effect of air on health in Le Havre. Pollution atmosphérique 1994; 36(143): 133-142, (accessed May 2009).
39. Gielen MH, van der Zee SC, van Wijnen JH, van Steen CJ, Brunekreef B. Acute effects of summer air pollution on respiratory health of asthmatic children. Am J Respir Crit Care Med 1997; 155: 2105-2108.
40. Tiitanen P, Timonen KL, Ruskanen JJ, Mirme A, Pekkanen J. Fine particulate air pollution, resuspended road dust and respiratory health among symptomatic children. Eur Respir J 1999; 13: 266-273.
41. Dusseldorp A, Kruize H, Brunekreef B, Hofschreuder P, de Meer G, van Oudvorst AB. Associations of PM10 and airborne iron with respiratory health of adults near a steel factory. Am J Respir Crit Care Med 1995; 152: 1932-1939.
42. Lenth RV. Some practical guidelines for effective sample size determination. Am Statist 2001; 55(3): 187-193.
43. Sistrom CL, Garvan CW. Proportions, odds, and risk. Radiology 2004; 230(1): 12-19.
44. WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services. Introduction to Drug Utilization Research. World Health Organization 2003.
45. Bergman U. The history of the Drug Utilization Research Group in Europe. Pharmacoepidemiol. Drug Saf 2006; 15(2): 95-98.
46. Maio V, Yuen E, Rabinowitz C, et al. Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy. J Health Serv Res Policy 2005; 10(4): 1317-1322.
47. Sartor F, Walckiers D. Estimate of disease prevalence using drug consumption data. Am J Epidemiol 1995; 141(8): 782-787.
48. Osborne ML, Vollmer WL, Johnson RE, Buist S. Use of an automated prescription database to identify individuals with asthma. J Clin Epidemiol 1995; 48(11): 1393-1397.
49. Monfared AA, Lelorier J. Accuracy and validity of using medical claims data to identify episodes of hospitalizations in patients with COP. Pharmacoepidemiol Drug Saf 2006; 15(1): 19-29.